Strides Pharma Science Ltd STAR

Morningstar Rating
₹1,095.30 −5.30 (0.48%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

STAR is trading at a LOCK|r^d^fq premium.
Price
₹1,095.30
Fair Value
LOCK|&<.@GNZ$%Mq
Uncertainty
LOCK|!V$q
1-Star Price
LOCK|RX.Y?VZ#>^
5-Star Price
LOCK|W>.w<&hq&
Economic Moat
LOCK|d<
Capital Allocation
—

Trading Information

Previous Close Price
₹1,100.60
Day Range
₹1,067.00–1,106.10
52-Week Range
₹768.65–1,260.90
Bid/Ask
₹1,080.10 / ₹1,095.30
Shares Outstanding
92.17M
Market Cap
₹100.96B
Volume/Avg
420,852 / 366,826

Key Statistics

Price/Earnings (Normalized)
19.32
Price/Sales
2.02
Dividend Yield (Trailing)
0.46%
Dividend Yield (Forward)
0.46%
Dividend Payment Schedule
Aug
Total Yield
0.46%

Company Profile

Strides Pharma Science Ltd is into the development and manufacture of pharmaceutical products. The company has single segment Pharmaceutical. Pharmaceutical segment represents the business of development, manufacture and Commercialization of pharmaceutical products other than biological drugs. It has presence in North America, Australia, Africa, Europe, and India. The company generates majority of revenue from North America.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
4,050

Valuation

Metric
STAR
Price/Earnings (Normalized)
19.32
Price/Book Value
3.25
Price/Sales
2.02
Price/Cash Flow
16.14
Price/Earnings
STAR

Financial Strength

Metric
STAR
Quick Ratio
0.60
Current Ratio
1.25
Interest Coverage
5.35
Quick Ratio
STAR

Profitability

Metric
STAR
Return on Assets (Normalized)
—
Return on Equity (Normalized)
—
Return on Invested Capital (Normalized)
—
Return on Assets
STAR

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|kN@v^VdLOCK|xM!F$66B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|kLN>Mb#LOCK|X?!^P$45B
Haleon PLC ADR
HLN
LOCK|$s@##pLOCK|&@#$40B
Zoetis Inc Class A
ZTS
LOCK|<HcsRwFLOCK|#^Q$30B
Viatris Inc
VTRS
LOCK|mrkJ%@LOCK|q^K$20B
Elanco Animal Health Inc
ELAN
LOCK|R$rLOCK|%m$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|V$Csj%LOCK|c#$10B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|GJScLw#LOCK|Lk#$7B
Prestige Consumer Healthcare Inc
PBH
LOCK|nbQp>!PLOCK|m#JN$2B
Perrigo Co PLC
PRGO
LOCK|!r#!s^LOCK|<t$2B

Sponsor Center